Literature DB >> 33154106

An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike.

Michael Schoof1,2, Bryan Faust3,2,4,5, Reuben A Saunders3,6, Smriti Sangwan3,2, Veronica Rezelj7, Nick Hoppe4,5, Morgane Boone3,2, Christian B Billesbølle4,5, Cristina Puchades5, Caleigh M Azumaya5, Huong T Kratochvil5, Marcell Zimanyi3,2, Ishan Deshpande4,5, Jiahao Liang4, Sasha Dickinson5, Henry C Nguyen5, Cynthia M Chio5, Gregory E Merz5, Michael C Thompson5, Devan Diwanji5, Kaitlin Schaefer5, Aditya A Anand3,2, Niv Dobzinski3,2, Beth Shoshana Zha8, Camille R Simoneau9,10,11, Kristoffer Leon9,10,11, Kris M White12,13, Un Seng Chio5, Meghna Gupta5, Mingliang Jin5, Fei Li5, Yanxin Liu5, Kaihua Zhang5, David Bulkley5, Ming Sun5, Amber M Smith5, Alexandrea N Rizo5, Frank Moss5, Axel F Brilot5, Sergei Pourmal5, Raphael Trenker5, Thomas Pospiech5, Sayan Gupta14, Benjamin Barsi-Rhyne4, Vladislav Belyy3,2, Andrew W Barile-Hill15, Silke Nock3,2, Yuwei Liu3,2, Nevan J Krogan5,6,9,10, Corie Y Ralston14, Danielle L Swaney5,6,9,10, Adolfo García-Sastre12,13,16,17, Melanie Ott9,10,11, Marco Vignuzzi7, Peter Walter1,2, Aashish Manglik18,5,9,19.   

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus enters host cells via an interaction between its Spike protein and the host cell receptor angiotensin-converting enzyme 2 (ACE2). By screening a yeast surface-displayed library of synthetic nanobody sequences, we developed nanobodies that disrupt the interaction between Spike and ACE2. Cryo-electron microscopy (cryo-EM) revealed that one nanobody, Nb6, binds Spike in a fully inactive conformation with its receptor binding domains locked into their inaccessible down state, incapable of binding ACE2. Affinity maturation and structure-guided design of multivalency yielded a trivalent nanobody, mNb6-tri, with femtomolar affinity for Spike and picomolar neutralization of SARS-CoV-2 infection. mNb6-tri retains function after aerosolization, lyophilization, and heat treatment, which enables aerosol-mediated delivery of this potent neutralizer directly to the airway epithelia.
Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33154106      PMCID: PMC7857409          DOI: 10.1126/science.abe3255

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   63.714


  59 in total

1.  MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy.

Authors:  Shawn Q Zheng; Eugene Palovcak; Jean-Paul Armache; Kliment A Verba; Yifan Cheng; David A Agard
Journal:  Nat Methods       Date:  2017-02-27       Impact factor: 28.547

2.  The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex.

Authors:  Berend Jan Bosch; Ruurd van der Zee; Cornelis A M de Haan; Peter J M Rottier
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

3.  A novel coronavirus associated with severe acute respiratory syndrome.

Authors:  Thomas G Ksiazek; Dean Erdman; Cynthia S Goldsmith; Sherif R Zaki; Teresa Peret; Shannon Emery; Suxiang Tong; Carlo Urbani; James A Comer; Wilina Lim; Pierre E Rollin; Scott F Dowell; Ai-Ee Ling; Charles D Humphrey; Wun-Ju Shieh; Jeannette Guarner; Christopher D Paddock; Paul Rota; Barry Fields; Joseph DeRisi; Jyh-Yuan Yang; Nancy Cox; James M Hughes; James W LeDuc; William J Bellini; Larry J Anderson
Journal:  N Engl J Med       Date:  2003-04-10       Impact factor: 91.245

4.  Structures and distributions of SARS-CoV-2 spike proteins on intact virions.

Authors:  Zunlong Ke; Joaquin Oton; Kun Qu; Mirko Cortese; Vojtech Zila; Lesley McKeane; Takanori Nakane; Jasenko Zivanov; Christopher J Neufeldt; Berati Cerikan; John M Lu; Julia Peukes; Xiaoli Xiong; Hans-Georg Kräusslich; Sjors H W Scheres; Ralf Bartenschlager; John A G Briggs
Journal:  Nature       Date:  2020-08-17       Impact factor: 49.962

5.  cisTEM, user-friendly software for single-particle image processing.

Authors:  Timothy Grant; Alexis Rohou; Nikolaus Grigorieff
Journal:  Elife       Date:  2018-03-07       Impact factor: 8.140

6.  A pneumonia outbreak associated with a new coronavirus of probable bat origin.

Authors:  Peng Zhou; Xing-Lou Yang; Xian-Guang Wang; Ben Hu; Lei Zhang; Wei Zhang; Hao-Rui Si; Yan Zhu; Bei Li; Chao-Lin Huang; Hui-Dong Chen; Jing Chen; Yun Luo; Hua Guo; Ren-Di Jiang; Mei-Qin Liu; Ying Chen; Xu-Rui Shen; Xi Wang; Xiao-Shuang Zheng; Kai Zhao; Quan-Jiao Chen; Fei Deng; Lin-Lin Liu; Bing Yan; Fa-Xian Zhan; Yan-Yi Wang; Geng-Fu Xiao; Zheng-Li Shi
Journal:  Nature       Date:  2020-02-03       Impact factor: 69.504

7.  Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation.

Authors:  Daniel Wrapp; Nianshuang Wang; Kizzmekia S Corbett; Jory A Goldsmith; Ching-Lin Hsieh; Olubukola Abiona; Barney S Graham; Jason S McLellan
Journal:  Science       Date:  2020-02-19       Impact factor: 47.728

8.  A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster.

Authors:  Jasper Fuk-Woo Chan; Shuofeng Yuan; Kin-Hang Kok; Kelvin Kai-Wang To; Hin Chu; Jin Yang; Fanfan Xing; Jieling Liu; Cyril Chik-Yan Yip; Rosana Wing-Shan Poon; Hoi-Wah Tsoi; Simon Kam-Fai Lo; Kwok-Hung Chan; Vincent Kwok-Man Poon; Wan-Mui Chan; Jonathan Daniel Ip; Jian-Piao Cai; Vincent Chi-Chung Cheng; Honglin Chen; Christopher Kim-Ming Hui; Kwok-Yung Yuen
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

9.  Distinct conformational states of SARS-CoV-2 spike protein.

Authors:  Yongfei Cai; Jun Zhang; Tianshu Xiao; Hanqin Peng; Sarah M Sterling; Richard M Walsh; Shaun Rawson; Sophia Rits-Volloch; Bing Chen
Journal:  Science       Date:  2020-07-21       Impact factor: 47.728

10.  Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms.

Authors:  M Alejandra Tortorici; Martina Beltramello; Florian A Lempp; Dora Pinto; Ha V Dang; Laura E Rosen; Matthew McCallum; John Bowen; Andrea Minola; Stefano Jaconi; Fabrizia Zatta; Anna De Marco; Barbara Guarino; Siro Bianchi; Elvin J Lauron; Heather Tucker; Jiayi Zhou; Alessia Peter; Colin Havenar-Daughton; Jason A Wojcechowskyj; James Brett Case; Rita E Chen; Hannah Kaiser; Martin Montiel-Ruiz; Marcel Meury; Nadine Czudnochowski; Roberto Spreafico; Josh Dillen; Cindy Ng; Nicole Sprugasci; Katja Culap; Fabio Benigni; Rana Abdelnabi; Shi-Yan Caroline Foo; Michael A Schmid; Elisabetta Cameroni; Agostino Riva; Arianna Gabrieli; Massimo Galli; Matteo S Pizzuto; Johan Neyts; Michael S Diamond; Herbert W Virgin; Gyorgy Snell; Davide Corti; Katja Fink; David Veesler
Journal:  Science       Date:  2020-09-24       Impact factor: 47.728

View more
  141 in total

1.  SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma.

Authors:  Jinal N Bhiman; Penny L Moore; Constantinos Kurt Wibmer; Frances Ayres; Tandile Hermanus; Mashudu Madzivhandila; Prudence Kgagudi; Brent Oosthuysen; Bronwen E Lambson; Tulio de Oliveira; Marion Vermeulen; Karin van der Berg; Theresa Rossouw; Michael Boswell; Veronica Ueckermann; Susan Meiring; Anne von Gottberg; Cheryl Cohen; Lynn Morris
Journal:  Nat Med       Date:  2021-03-02       Impact factor: 53.440

2.  Engineered single-domain antibodies tackle COVID variants.

Authors:  James E Voss
Journal:  Nature       Date:  2021-07       Impact factor: 49.962

3.  Integrative proteomics identifies thousands of distinct, multi-epitope, and high-affinity nanobodies.

Authors:  Yufei Xiang; Zhe Sang; Lirane Bitton; Jianquan Xu; Yang Liu; Dina Schneidman-Duhovny; Yi Shi
Journal:  Cell Syst       Date:  2021-02-15       Impact factor: 10.304

4.  Inhalable Nanobody (PiN-21) prevents and treats SARS-CoV-2 infections in Syrian hamsters at ultra-low doses.

Authors:  Sham Nambulli; Yufei Xiang; Natasha L Tilston-Lunel; Linda J Rennick; Zhe Sang; William B Klimstra; Douglas S Reed; Nicholas A Crossland; Yi Shi; W Paul Duprex
Journal:  Sci Adv       Date:  2021-05-26       Impact factor: 14.136

Review 5.  50 Years of Structural Immunology.

Authors:  Ian A Wilson; Robyn L Stanfield
Journal:  J Biol Chem       Date:  2021-05-03       Impact factor: 5.157

Review 6.  SARS-CoV-2 cell entry and targeted antiviral development.

Authors:  Zinuo Chen; Ruikun Du; Jazmin M Galvan Achi; Lijun Rong; Qinghua Cui
Journal:  Acta Pharm Sin B       Date:  2021-05-13       Impact factor: 11.413

7.  Nanobody Repertoires for Exposing Vulnerabilities of SARS-CoV-2.

Authors:  Fred D Mast; Peter C Fridy; Natalia E Ketaren; Junjie Wang; Erica Y Jacobs; Jean Paul Olivier; Tanmoy Sanyal; Kelly R Molloy; Fabian Schmidt; Magda Rutkowska; Yiska Weisblum; Lucille M Rich; Elizabeth R Vanderwall; Nicolas Dambrauskas; Vladimir Vigdorovich; Sarah Keegan; Jacob B Jiler; Milana E Stein; Paul Dominic B Olinares; Theodora Hatziioannou; D Noah Sather; Jason S Debley; David Fenyö; Andrej Sali; Paul D Bieniasz; John D Aitchison; Brian T Chait; Michael P Rout
Journal:  bioRxiv       Date:  2021-04-10

8.  Implementing a method for engineering multivalency to substantially enhance binding of clinical trial anti-SARS-CoV-2 antibodies to wildtype spike and variants of concern proteins.

Authors:  Adam Leach; Ami Miller; Emma Bentley; Giada Mattiuzzo; Jemima Thomas; Craig McAndrew; Rob Van Montfort; Terence Rabbitts
Journal:  Sci Rep       Date:  2021-05-18       Impact factor: 4.379

Review 9.  Prospects of Neutralizing Nanobodies Against SARS-CoV-2.

Authors:  Fangfang Chen; Zhihong Liu; Fan Jiang
Journal:  Front Immunol       Date:  2021-05-28       Impact factor: 7.561

Review 10.  Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy.

Authors:  Qianqian Zhang; Rong Xiang; Shanshan Huo; Yunjiao Zhou; Shibo Jiang; Qiao Wang; Fei Yu
Journal:  Signal Transduct Target Ther       Date:  2021-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.